Methodological Standardization in Knee Joint Ultrasound: A  
Comprehensive Research Procedure  
Kaneez Abbas1, M. Asif Ali2, Alireza Mobasseri3, Mahdi Khanbabazadeh4, Bala Balaguru1, Hadi  
Khazaei1*  
1Athreya Medtech, USA  
2DeCure Center, USA  
3Shahroud University of Medical Sciences, USA  
4Chiro-Care Chiropractic Clinic, USA  
*Corresponding Author  
Received: 29 October 2025; Accepted: 05 November 2025; Published: 21 November 2025  
ABSTRACT  
Background: Knee ultrasonography is a key diagnostic and research tool for evaluating joint effusion, synovitis, tendon,  
and ligament integrity. Despite its widespread use, methodological inconsistencies across studiesranging from patient  
positioning to probe settingslimit reproducibility and cross-study comparability.  
Objective: To outline a standardized, evidence-based procedure for knee joint ultrasound suitable for research  
applications, aligning with international guidelines to ensure methodological rigor and reproducibility.  
Methods: A comprehensive research framework was developed incorporating standardized participant selection,  
equipment calibration, scanning parameters, patient positioning, and both static and dynamic maneuvers  
Results: Implementing standardized ultrasound protocols minimizes measurement variability, improves the accuracy of  
synovial and vascularity assessment, and enhances longitudinal monitoring of therapeutic responses.  
Conclusion: Methodological standardization in knee ultrasound strengthens data validity, promotes reproducibility, and  
facilitates integration of imaging biomarkers into clinical and translational musculoskeletal research. The outlined  
framework serves as a template for future multicenter and longitudinal ultrasound studies.  
Keywords: Knee ultrasound; musculoskeletal imaging; methodological standardization; dynamic ultrasound; research  
protocol.  
INTRODUCTION  
Musculoskeletal ultrasound (MSUS) is an indispensable modality for evaluating the knee joint’s soft tissues,  
articular cartilage, synovium, tendons, and ligaments. Its portability, lack of ionizing radiation, and ability to  
provide real-time dynamic assessment make it a valuable tool for both clinical and research purposes. Despite  
its diagnostic strengths, methodological heterogeneityspanning equipment parameters, patient positioning,  
scanning planes, and image interpretationhas limited reproducibility and cross-study consistency.  
Recognizing this gap, international working groups such as EularOmeract and EURO-Musculus/Usprm have  
emphasized the need for standardized scanning procedures and scoring systems. These frameworks  
recommend detailed specifications on probe frequency, Doppler gain, patient posture, region of interest  
selection, and timing related to interventions such as injections or physiotherapy. Adherence to such  
methodological rigor ensures that ultrasound findings reflect true biological changes rather than procedural  
variability.  
Page 2022  
A comprehensive, standardized approach is therefore crucial for generating reliable, comparable data across  
research centers. The present framework consolidates evidence-based procedural stepscovering participant  
inclusion criteria, equipment settings, scanning techniques, and data analysisinto a unified, reproducible  
model for knee joint ultrasound research.  
Study Design and Participant Selection  
1. A randomized, controlled, or observational cohort design is typically used depending on research  
objectives.  
2. Participants are recruited based on inclusion and exclusion criteria relevant to the pathology under  
study (e.g., osteoarthritis, ligament injury).  
3. Baseline demographics, clinical assessment (pain scores, KOOS/WOMAC), and prior imaging  
(radiographs when applicable) are documented.  
1. Randomized Controlled Trial (RCT)  
1. Most rigorous option for assessing treatment effect.  
2. Patients with musculoskeletal inflammatory disorders (e.g., tendinopathies, fasciitis, arthritis) would be  
randomized into:  
Intervention group → receives galvanic therapy.  
Control group → sham therapy, standard care, or no treatment.  
1. Ultrasound imaging would be done pre- and post-intervention to assess objective changes (e.g., vascularity,  
echogenicity, tendon thickness, effusion).  
2. Advantage: establishes causality and minimizes bias.  
3. Limitation: more resource-intensive, ethical considerations if sham therapy is used.  
2. Controlled Clinical Trial (Non-randomized)  
1. Patients are allocated into groups but not randomized.  
2. Ultrasound outcomes compared between galvanic therapy and usual care.  
3. Easier to conduct than RCT, but higher risk of selection bias.  
3. Observational Cohort (Prospective or Retrospective)  
Prospective cohort:  
1. Patients receiving galvanic therapy are followed over time.  
2. Ultrasound findings compared before and after treatment.  
3. Sometimes a control group (no galvanic therapy) is included.  
Retrospective cohort:  
1. Use existing medical records and ultrasound reports before/after galvanic therapy.  
2. Advantage: more feasible, lower cost.  
3. Limitation: can only show association, not causation. Susceptible to confounding factors.  
Page 2023  
4. Pre-Post (Within-Subject) Design  
1. Single-arm study: patients serve as their own controls.  
2. Ultrasound performed pre-treatment and post-treatment (short- and/or long-term follow-up).  
3. Advantage: simple and cost-effective, good for pilot/feasibility studies.  
4. Limitation: lacks a control group → changes may reflect natural healing or placebo effects.  
Core inclusion criteria  
Age: 1850 years.  
Rationale: adult population; the upper age limit is selected based on the possible beginning of knee osteoarthritis in  
individuals over 50.  
Clinical diagnosis of a focal musculoskeletal inflammatory condition at a single anatomical site (examples: Achilles  
tendinopathy, plantar fasciitis, trochanteric bursitis) based on history and exam.  
Symptoms of at least 6 weeks’ duration but ≤24 months.  
Rationale: exclude very acute self-resolving cases; allow subacutechronic instances where intervention is relevant.  
Modify bounds based on the target population.  
Baseline pain/disability threshold: e.g., average pain ≥4/10 on VAS over the prior week OR functional score below a  
site-specific cutoff (VISA-A <70 for Achilles).  
Rationale: ensures clinically meaningful baseline severity.  
Ultrasound confirmation of inflammatory features at the target site on screening scan, defined as at least one of:  
1. Power Doppler signal ≥ Grade 1 within ROI (semiquantitative 0–3), OR  
2. Hypoechoic tendon area consistent with tendinopathy plus peritendinous fluid/effusion, OR  
3. Bursal thickening with Doppler signal.  
4. Rationale: ensures imaging-visible inflammation that can be measured pre-post.  
Willingness & ability to attend treatment sessions and follow-up scans, and provide informed consent.  
Core exclusion criteria  
1. Implanted electrical medical device (e.g., pacemaker, ICD, deep brain stimulator) or cardiac conduction device  
where  
electrical  
stimulation  
is  
contraindicated.  
Rationale: safety risk with external electrical currents.  
2. Pregnancy or breastfeeding.  
Rationale: unknown safety; regulatory/IRB caution.  
3. Local skin lesions or infection at electrode sites (open wound, cellulitis, severe dermatitis) or broken skin  
preventing safe electrode placement.  
4. Known epilepsy or uncontrolled seizure disorder (if your institutional safety policy considers electrical  
stimulation a risk).  
Rationale: some protocols exclude uncontrolled seizures for electrical stimulation studies.  
Page 2024  
5. Current systemic inflammatory disease with active systemic therapy likely to change local inflammation  
rapidly (e.g., newly started/changed dose within prior 3 months of systemic corticosteroids, biologic DMARDs).  
Consider excluding patients on high-dose systemic steroids (>10 mg prednisone equivalent/day).  
Rationale: systemic treatments confound local imaging response.  
6. Local corticosteroid injection at the target site within the prior 3 months (or other local biologic injection  
such  
as  
PRP  
within  
6
months),  
or  
scheduled  
injection  
during  
study  
period.  
Rationale: injections have large effects on ultrasound and symptoms.  
7. Planned surgery at the target site during the follow-up period or significant structural lesion incompatible  
with conservative therapy (e.g., full-thickness tendon rupture requiring surgery).  
Rationale: prevents mixing surgical outcomes with therapy effects.  
8. Severe peripheral neuropathy or sensory loss at the treatment area (e.g., advanced diabetic neuropathy) if it  
impairs the ability to sense stimulation or increases the risk of burns. Use of anticoagulation or bleeding diathesis  
that, in the investigator’s judgment, makes repeated electrode placement unsafe, or active skin bleeding disorders  
at the site. (This can be site-specific; many trials allow stable anticoagulation.)  
9. Concurrent participation in another interventional clinical trial for the same condition. Inability to comply  
with follow-up or provide consent (e.g., cognitive impairment, planned relocation). Symptom duration  
floor/ceiling adjustments: e.g., require ≥3 months for chronic tendinopathy studies; extend upper limit beyond 24  
months if you want long-standing cases. Limit to a single site or unilateral disease to simplify ultrasound ROI  
and analysis (exclude bilateral symptomatic cases unless you will treat only one side). Medication stability  
window: require a stable analgesic/NSAID dose for the prior 2 weeks and throughout the study, or record doses  
as covariates. Exclude prior major surgery at the same site (e.g., previous tendon repair) if it changes baseline  
anatomy and imaging interpretation. Limit to certain imaging severity: e.g., include only PD grade 13 but  
exclude structural grade indicating degeneration > specified threshold. Exclude diabetes with HbA1c > X if  
wound healing or neuropathy is a concern.  
10. Age subgroup restrictions (e.g., exclude >65) if device safety has not been tested in older adults.  
Imaging-specific exclusions/requirements  
1. Must have baseline ultrasound with documented PD grade and image that meets SOP (machine settings, ROI).  
2. Exclude if baseline imaging shows a frank full-thickness tear, large retraction, or surgical hardware in the ROI.  
3. Standardize timing: do not allow baseline ultrasound within 48 hours after injection or an intense physical  
therapy session that could transiently alter vascularity.  
Screening tests & baseline assessments  
1. Targeted medical history/medications (recent steroids, biologics, anticoagulants).  
2. Pregnancy test for women of childbearing potential.  
3. Device/implant checklist (pacemaker, etc.).  
4. Baseline ultrasound with standardized protocol (store images/DICOM).  
5. Baseline VAS pain, validated functional score (VISA-A, WOMAC, etc.), and analgesic use log.  
6. Safety labs only if clinically indicated (not routinely required).  
Rationale & practical notes  
1. Excluding recent local injections and recent systemic therapy changes is crucial because they produce large  
imaging changes that confound treatment effect attribution to galvanic therapy.  
Page 2025  
2. Requiring ultrasound-confirmed inflammation ensures you measure a population where imaging can detect  
change; otherwise, you risk floor effects.  
3. Safety exclusions (implanted electrical devices, pregnancy, open skin) are standard for electrical stimulation  
interventions.  
4. Be explicit about timing windows (e.g., “no steroid injection within 3 months prior to baseline ultrasound; no  
new systemic immunomodulators within 3 months”) in the protocol.  
Baseline Assessment  
1. Pain score: VAS 010 at rest and activity.  
2. Functional score: KOOS for knee, DASH for elbow.  
3. Ultrasound: standardized acquisition with PD vascularity grade, tendon thickness (mm), effusion/bursal volume  
(ml or mm), and synovial hypertrophy grade.  
4. Photography: store DICOM or cine loops for blinded central review.  
5. Concomitant meds/therapies: NSAIDs, physiotherapy, braces.  
SOP  
A standard procedure for a research project involving ultrasound of the knee joint includes several core steps to ensure  
methodological rigor, reproducibility, and alignment with clinical standards. These steps address participant selection,  
equipment, scanning protocol, assessment features, outcome measurement, and data analysis.  
Study Design and Participant Selection  
1. A randomized, controlled, or observational cohort design is typically used depending on research objectives.  
2. Participants are recruited based on inclusion and exclusion criteria relevant to the pathology under study (e.g.,  
osteoarthritis, ligament injury).  
3. Baseline demographics, clinical assessment (pain scores, KOOS/WOMAC), and prior imaging (radiographs  
when applicable) are documented.  
Ultrasound Equipment and Settings  
1. High-frequency linear transducers (715 MHz) are recommended for optimal resolution of superficial knee  
structures.  
2. Equipment settings, including depth, gain, and focus, should be standardized before each scan to reduce  
variability.  
Standardized Scanning Protocol  
The protocol should specify patient positioning (usually supine with knee in extension or slight flexion).  
A systematic scanning order covers:  
1. Suprapatellar region (for effusion and synovitis)  
2. Medial and lateral joint lines (menisci, collateral ligaments)  
3. Anterior knee (quadriceps and patellar tendons)  
4. Posterior knee (popliteal cysts, hamstring tendons)  
5. Dynamic maneuvers (e.g., valgus/varus stress) may be used to assess ligament integrity and joint instability.  
Page 2026  
Structures and Pathology to Assess  
1. Commonly assessed features include synovial effusion, synovitis, osteophytes, meniscal extrusion,  
ligament/tendon injury, and cartilage status.  
2. Scoring systems or atlases may be employed for semiquantitative assessment of features (effusion, osteophyte,  
synovial hypertrophy, etc.).  
3. Both grayscale and, when indicated, Doppler imaging are used to evaluate vascularity and inflammatory  
changes.  
Outcome Measurement and Data Collection  
1. Standardized forms and digital image archiving are used for data capture.  
2. Outcomes include changes in clinical scores (pain, function), ultrasound findings, and, in interventional studies,  
response to treatment.  
3. Inter- and intra-reader reliability is often assessed for protocol validation.  
Ethical Considerations and Quality Assurance  
1. Ethics committee approval and informed consent are required.  
2. Sonographer and reader training are crucial for reproducibility and reliability.  
Data Analysis  
1. Correlations between ultrasound findings and clinical/radiographic outcomes are statistically analyzed.  
2. Protocols usually specify blinding of image interpreters to clinical information to reduce bias.  
Figure 1. Study design for effective assessment in knee joint ultrasound  
Step-by-Step Dynamic Maneuvers  
Step-by-step dynamic maneuvers for knee ultrasound combine specific patient movements and transducer placements to  
assess ligamentous, tendinous, and joint integrity. Example images from validated teaching atlases and protocols  
optimize training and reproducibility.  
Page 2027  
Valgus Stress Test (Medial Collateral Ligament)  
1. Patient supine, knee flexed 2030°.  
2. Apply valgus pressure while placing the transducer over the medial joint line.  
3. Observe for MCL fiber continuity and gapping.  
4. Example labeled image: Medial knee with fiber strain/gapping.  
Varus Stress Test (Lateral Collateral Ligament)  
1. Patient supine, knee flexed.  
2. Apply varus pressure, transducer on the lateral joint line.  
3. Assess LCL continuity and laxity.  
4. Example labeled image: Lateral collateral ligament under stress.  
Quadriceps Activation Test  
1. Patient contracts quadriceps (extension), transducer over the suprapatellar region.  
2. Evaluate femoral cartilage movement and patellar tendon distension.  
3. Example image: Suprapatellar view labeled for quadriceps activation.  
Baker’s Cyst Compression  
1. Patient prone, knee extended.  
2. Gentle pressure compresses the popliteal fossa. The transducer visualizes cyst shape/change.  
3. Example image: Popliteal cyst labeled with compression effect.  
Meniscal Mobility  
1. Patient's knee flexed, transducer along the joint line.  
2. Perform passive flexion-extension and valgus-varus maneuvers.  
3. Visualize meniscal extrusion/movement.  
4. Example image: Medial meniscus labeled under dynamic maneuver.  
Accessing Example Labeled Images  
1. EURO-MUSCULUS/USPRM knee protocol PDF includes labeled example images for each dynamic maneuver  
and anatomical area.  
2. Netter-based teaching atlases (Jacobson, MSKUS) provide stepwise diagrams paired with dynamic scans for  
clinical and research training.  
Using these resources, research and clinical teams can standardize dynamic ultrasound maneuvers with reference images  
to guide training, documentation, and scoring.  
Knee Ultrasound Protocol  
1. Knee compartments: Anterior, Medial, Lateral, Posterior  
Page 2028  
2. Key structures to label: Quadriceps tendon, Patellar tendon, Suprapatellar bursa, Prepatellar bursa, Infrapatellar  
tendon, Medial and Lateral Collateral Ligaments (MCL, LCL), Menisci (medial and lateral), Popliteal fossa  
structures (including popliteal artery and vein)  
3. Typical scanning planes: Long axis (LA) and Short axis (SA) views for tendons and ligaments  
4. Patient positioning: Supine for anterior, medial, lateral views; prone for posterior  
5. The knee is divided into four compartments: Anterior, Medial, Lateral, and Posterior.  
6. For each compartment, key anatomical structures are labeled with directional arrows.  
7. Anterior compartment includes: Quadriceps tendon (long and short axis), Suprapatellar bursa, Patella, Patellar  
tendon (long and short axis), and Infrapatellar tendon.  
8. Medial compartment includes: Medial collateral ligament (MCL), Medial meniscus, Pes anserinus tendons, and  
bursa.  
9. Lateral compartment includes: Lateral collateral ligament (LCL), Lateral meniscus, and Iliotibial band.  
10. Posterior compartment includes: Popliteal artery and vein, Semimembranosus tendon, Gastrocnemius muscle,  
Popliteal fossa.  
11. Typical probes used: High-frequency linear probe (7-15 MHz).  
12. Patient positioning cues: Supine for anterior/medial/lateral scans, prone for posterior.  
Figure 2. Representative clinical and ultrasound images showing probe placement and sonographic findings in  
musculoskeletal tendon evaluation.  
(a) Anterior knee: probe positioning over the patellar tendon and corresponding longitudinal ultrasound images  
demonstrating tendon morphology and echotexture.  
(b) Posterior ankle: probe placement along the Achilles tendon and associated sonograms showing normal fibrillar  
pattern and insertional anatomy.  
Page 2029  
Figure 3. Knee ultrasound demonstrating normal pediatric knee anatomy. This linear probe image confirms the presence  
of the open physis (growth plate) separating the femoral metaphysis and epiphysis. The hypoechoic layer of cartilage and  
the A/P depth in the suprapatellar recess (blue star) are crucial for assessing joint integrity and effusion.  
Ultrasound Scanning Checklist  
Patient Positioning  
1. Supine with knee flexed 20-30 degrees with support under the knee (anterior, medial, lateral scans)  
2. Prone with knee slightly flexed and supported (posterior scans)  
Probe Type  
High-frequency linear probe (7-15 MHz)  
Scanning Regions and Probe Positions  
Region  
Probe Position/Orientation  
Key Structures to Scan  
Notes  
Anterior  
Knee  
Probe longitudinally over the Quadriceps tendon, suprapatellar bursa, Use ample gel over the  
quadriceps tendon  
patella  
prepatellar area  
Probe longitudinally and transversely Patellar tendon, infrapatellar bursa  
over the patellar tendon  
Examine the tendon  
insertion on the tibial  
tuberosity  
Medial  
Knee  
Probe longitudinally over the medial Medial collateral ligament (MCL), Assess  
MCL  
and  
collateral ligament  
medial meniscus, pes anserinus bursa  
adjoining  
borders  
meniscal  
Probe transversely along the pes Sartorius, gracilis, and semitendinosus  
anserinus tendons tendons  
Lateral  
Knee  
Probe longitudinally over the lateral Lateral collateral ligament (LCL), lateral Adjust the probe angle  
collateral ligament  
meniscus, and iliotibial band  
slightly posteriorly  
Posterior  
Patient prone, probe transverse and Popliteal  
artery and  
vein, Slight flexion enhances  
semimembranosus-gastrocnemius bursa,  
Page 2030  
Knee  
longitudinal in the popliteal fossa  
posterior capsule  
venous filling  
Scan Planes  
1. Use both long axis (longitudinal) and short axis (transverse) views for tendons and ligaments  
2. Evaluate dynamic changes with patient knee movement if possible  
Key Assessment Points  
1. Fluid collections (bursae, joint recesses)  
2. Tendon integrity (tears, thickness)  
3. Ligament continuity and thickening  
4. Meniscus shape and surface (bulges, cysts)  
5. Neurovascular structures (popliteal artery/vein patency)  
6. Pathology documentation: measure fluid collections, cysts, vascularity  
Scanning Techniques  
The technique below demonstrates how to identify normal anatomy. Remember to assess all musculoskeletal anatomy  
dynamically and thoroughly.  
Divide the knee into 4 compartments.  
1. Anterior  
2. Medial  
3. Lateral  
4. Posterior  
Anterior Knee  
Transverse scan plane for the quadriceps  
Transverse suprapatellar region:  
•RF: Rectus Femoris •VI: Vastus intermedius  
•VL: Vastus Lateralis •VM: Vastus Medialis  
Suprapatellar scan plane.  
Longitudinal suprapatellar region showing the suprapatellar bursa and quadriceps tendon.Prepatellar scan planeTo avoid  
loss of contact, use plenty of thick gel or a standoff.Infrapatellar scan plane.The infrapatellar tendon.Also called the  
patella ligament.  
The insertion of the infrapatellar tendon onto the tibial tuberosity. Note: The normal physiological amount of fluid is  
along the underside of the tendon.  
Transverse Infrapatellar tendon: Note its width to understand the area you need to examine longitudinally.  
Page 2031  
Figure 4. Longitudinal ultrasound image of the anterior knee demonstrating the patellar tendon extending from the  
inferior pole of the patella to the tibial tuberosity. The Hoffa fat pad is visualized deep to the tendon, and a hypoechoic  
area is noted at the distal tendon attachment, consistent with focal tendinopathy or partial tear.  
Medial Knee  
Medial collateral ligament (MCL) Joint space/meniscus Pes Anserinus.Medial knee joint scan plane.The medial  
collateral ligament (green) directly overlying the medial meniscus (purple).Pes anserinus scan plane.The Pes Anserine  
bursa and tendon insertion are medial to the Infrapatellar tendon on the tibia, adjacent to the MCL insertion.  
Remember the Pes Anserine tendons as (sergeant) SGT:  
Sartorius, Gracilis, and semi-tendinosis.  
Lateral Knee  
Lateral knee joint scan plane.Assess the Lateral collateral ligament, the Iliotibial band insertion, and the peripheral  
margins of the lateral meniscus. Unlike the medial side, the LCL is separated from the meniscus by a thin tissue plane.  
Ilio-Tibial Band.  
Rotate the probe off the LCL, with the toe of the probe angled slightly posteriorly.  
Posterior Knee  
Popliteal fossa scan planeMedial aspect of the popliteal fossa showing the semimembranosus/gastrocnemius  
plane.Ultrasound of the Popliteal vein and artery in transverse.Without and with compression to exclude DVT.  
Confirm both arterial and venous flow and exclude a popliteal artery aneurysm. If a Popliteal aneurysm is discovered,  
always extend the examination to the other leg and the abdomen. There is a risk of bilateral and high association with  
aortic aneurysm.  
Page 2032  
Figure 5. Ultrasound evaluation of the posterior knee showing probe placement and labeled sonographic anatomy. The  
semitendinosus (SemiT), semimembranosus (SemiM), medial gastrocnemius (MG), and popliteus muscle (PM) are  
visualized in relation to the femur, tibia, and medial meniscus (MM). The corresponding clinical image illustrates correct  
transducer positioning for posterior knee scanning.  
Scan Protocol  
Role of Ultrasound  
Ultrasound is essentially used for the external structures of the knee. It is a valuable diagnostic tool in assessing the  
following indications; Muscular, tendinous and ligamentous damage (chronic and acute), Bursitis, Joint effusion,  
Popliteal vascular pathology, Hematomas, Masses such as Baker’s cysts, Lipomas, for classification of a mass e.g. solid,  
cystic, or mixed; post-surgical complications e.g. abscess, oedema, Guidance of injection, aspiration or biopsy,  
Relationship of normal anatomy and pathology to each other.  
Limitations  
It is recognized that ultrasound offers little or no diagnostic information for internal structures such as the cruciate  
ligaments. Ultrasound complements other modalities, including plain X-ray, CT, MRI, and arthroscopy.  
Patient Preparation  
None required.  
Equipment setup  
Use of a high-resolution probe (7-15MHZ) is essential when assessing the superficial structures of the knee. Careful  
scanning technique to avoid anisotropy (and possible misdiagnosis). Beam steering or compounding can help to  
overcome anisotropy in linear structures such as tendons. Good color/power / Doppler capabilities when assessing  
vessels or vascularity of a structure. Be prepared to change the frequency output of the probe (or probes) to adequately  
assess both superficial and deeper structures.  
Common Pathology  
1. Joint effusion  
2. Baker's cyst  
Page 2033  
3. Collateral ligament injury  
4. Patella tendinopathy  
5. Meniscal bulging/cysts  
6. Quadriceps injury  
7. Pes anserine bursitis/tendinopathy  
8. Patella retinaculum pathology  
Scanning Technique  
Posterior Fossa  
Patient prone on bed, knee flexed slightly with a pad under the ankle for support. Survey the entire fossa to identify the  
normal anatomy, including the Popliteal artery and vein (patency, aneurysm, thrombosis), Posterior joint (joint effusion),  
and Medial popliteal fossa bursa between the semimembranosus tendon and medial gastrocnemius muscle (Baker’s cyst).  
Document the normal anatomy and any pathology found, including measurements and vascularity if indicated.  
Anterior Knee  
Patient lies supine on the bed with the knee flexed 20 30 degrees. Alternatively, the patient may sit on the side of a  
raised bed with the foot resting on the Sonographer’s knee for support. Identify the normal anatomy, including  
Quadriceps tendon (tears, M/T junction, tendonitis), Suprapatellar bursa (bursitis-simple/complex, synovial thickening,  
loose bodies), Patella (gross changes e.g. erosion, bipartite, fracture), Patella tendon (tears, tendonitis, insertion  
enthesopathy), Infrapatellar bursa (tendonitis, tears, bursitis, fat pad changes), and Infero-Medial Pes anserine bursa  
Lateral And Medial Knee  
May be scanned as above. Assess the medial and Lateral Collateral ligaments and meniscal margins. Joint lines (ligament  
tears or thickening, meniscal bulging/cysts, joint effusion, gross bony changes)  
Basic Hardcopy Imaging  
A knee series should include the following minimum images:  
1. Quadriceps tendon long, trans +/- MT junction  
2. Suprapatellar bursa  
3. Pre patella long  
4. Patella tendon long, trans, insertion onto tibial tuberosity  
5. Medial meniscus and MCL  
6. Lateral Meniscus and LCL  
7. Popliteal artery and vein to demonstrate patency  
8. Medial Popliteal Fossa  
9. Document the normal anatomy and any pathology found, including measurements and vascularity if indicated.  
Page 2034  
Figure 6. Knee Anatomy.  
A, Anterior view of the knee. B, Medial view of knee (From Drake R, Vogl W, Mitchell A: Gray’s Anatomy for  
Students. Philadelphia, 2005, Churchill Livingstone)  
CONCLUSION  
Establishing a standardized methodological framework for knee joint ultrasound ensures that imaging data are accurate,  
reproducible, and clinically interpretable. By aligning with internationally validated guidelines and incorporating  
reference images and dynamic maneuvers, researchers can reduce inter-observer variability and enhance study  
comparability. This structured protocol promotes methodological transparency and sets a foundation for high-quality,  
multicenter musculoskeletal ultrasound research.  
REFERENCES:  
1. Terslev L, Naredo E, Aegerter P, Wakefield RJ, Backhaus M, Balint P, et al. Scoring ultrasound synovitis in  
rheumatoid arthritis: a EULAROMERACT ultrasound taskforcepart 2: reliability and application to  
multiple joints. Ann Rheum Dis. 2017 Mar;76(3):42025.  
2. Silverwood V, Blagojevic-Bucknall M, Jinks C, Jordan JL, Protheroe J, Jordan KP. Current evidence on risk  
factors for knee osteoarthritis in older adults: a systematic review and meta-analysis. Osteoarthritis Cartilage.  
2015 Apr;23(4):50715.  
Page 2035  
3. Abbas K, Oteibi M, Khazaei D, Balaguru B, Etesami F, Khazaei H. Evaluation of AI-assisted ultrasound-  
guided galvanic therapy (AAUGGT) for the treatment of inflammation-induced pain versus other modalities.  
Int J Res Innov Appl Sci. 2025;10(2):703-714.  
4. Szkudlarek M, Court-Payen M, Strandberg C, Klarlund M, Klausen T, Østergaard M. Power Doppler  
ultrasonography for assessment of synovial inflammation in the metacarpophalangeal joints of patients with  
rheumatoid arthritis: a comparison with dynamic magnetic resonance imaging. Arthritis Rheum. 2001  
Sep;44(9):201823.  
5. Koski JM, Saarakkala S, Helle M, Hakulinen U, Heikkinen JO, Hermunen H. Power Doppler ultrasonography  
and synovitis: correlating ultrasound imaging with histopathological findings and evaluating different joint  
areas in rheumatoid arthritis. Ann Rheum Dis. 2010 Mar;69(3):54952.  
6. Abbas K, Oteibi M, Khajehee B, Khazaei H. AI-assisted ultrasound-guided electrical therapy for  
musculoskeletal disorders (AAUGET). Int J Res Innov Appl Sci. 2025;10(9):399-410.  
7. Naredo E, Valor L, De la Torre I, Montoro M, Bello N, Martínez-Barrio J, et al. Predictive value of Doppler  
ultrasound-detected synovitis in relation to short-term flare in patients with rheumatoid arthritis in clinical  
remission. Arthritis Rheum. 2013 Feb;65(2):37685.  
8. Backhaus M, Burmester GR, Gerber T, Grassi W, Machold KP, Swen WA, et al. Guidelines for  
musculoskeletal ultrasound in rheumatology. Ann Rheum Dis. 2001 Jul;60(7):64149.  
9. Bianchi S, Martinoli C. Ultrasound of the Musculoskeletal System. 2nd ed. Berlin: Springer; 2007. p. 801–  
820.  
10. 10.Abbas K, Oteibi M, Khajehee B, Khazaei H, Khazaei D, Balaguru B, Khanbabazadeh M. AAUGET AI-  
Assisted Ultrasound-Guided Electrical Therapy for Musculoskeletal Disorders. Int J Res Innov Appl Sci  
(IJRIAS). 2025;10(8):1005-17.  
11. Jacobson JA. Fundamentals of Musculoskeletal Ultrasound. 3rd ed. Philadelphia: Elsevier; 2017. p. 251273.  
12. Özçakar L, Kara M, Chang KV, Çarl AB, Akkaya N, Tok F, et al. EURO-MUSCULUS/USPRM basic  
scanning protocols for knee. Eur J Phys Rehabil Med. 2015 Dec;51(6):72126.  
13. Abbas K, Khajehee B, Khanbabazadeh M, Oteibi M, Khazaei H, Balaguru B. AI-Assisted Ultrasound-Guided  
Galvanic Therapy (AAUGGT) An Innovative Approach to Pain Management Fundamental Mechanisms,  
Biomedical and Technical Development. Int J Res Innov Appl Sci. 2025;10(7):1280-1291.  
Page 2036